www.japantimes.co.jp Open in urlscan Pro
2606:4700:20::681a:203  Public Scan

URL: https://www.japantimes.co.jp/news/2024/11/15/japan/science-health/lecanemab-drug-switch-recommendation/
Submission: On November 16 via api from LU — Scanned from JP

Form analysis 2 forms found in the DOM

GET /search

<form class="holder-search" method="GET" action="/search" id="headerSearchForm">
  <input class="form-field" type="text" placeholder="Search" name="query" autocomplete="off" id="query" required="">
  <button class="btn-submit" type="submit"><span class="search" id="toggleSearch"><img src="/theme_japantimes/images/search_icon.svg" alt="Search"></span></button>
</form>

GET /search

<form class="holder-search" method="GET" action="/search" id="headerSearchForm">
  <input class="form-field" type="text" placeholder="Search" name="query" autocomplete="off" id="query" required="">
  <button class="btn-submit" type="submit"><span class="search" id="toggleSearch"><img src="/theme_japantimes/images/search_icon.svg" alt="Search" width="16.5" height="16.5"></span></button>
</form>

Text Content

 
 * Subscribe
   Digital Print
 * 
 * 



 

November 17, 2024


 

Subscribe

Digital Print

 * Trump transition
 * LDP / DPP
 * ‘Yami baito’ burglaries
 * Latest News
 * Deep Dive

Today's print edition

Home Delivery

 * JAPAN
   * Politics
   * Society
   * Crime & Legal
   * Science & Health
   * Explainer
   * History
 * WORLD
   * Politics
   * Crime & Legal
   * Science & Health
   * Society
 * ASIA PACIFIC
   * Politics
   * Crime & Legal
   * Science & Health
   * Society
 * BUSINESS
   * Companies
   * Economy
   * Markets
   * Tech
 * SPORTS
   * Sumo
   * Soccer
   * Baseball
   * Basketball
   * Tennis
   * Olympics
   * More sports
 * OPINION
   * Editorials
   * Commentary
 * Environment
   * CLIMATE CHANGE
   * Energy
   * SUSTAINABILITY
   * WILDLIFE
   * EARTH SCIENCE
 * LIFE
   * Travel
   * Digital
   * Food & Drink
   * Style & Design
   * Language
   * Lifestyle
 * CULTURE
   * Film
   * Books
   * Music
   * Art
   * TV & Streaming
   * Stage
   * Entertainment news
 * COMMUNITY
   * Voices
   * Issues
   * How-tos
   * Our Lives

 * 
 * My Account
 * My Bookmarks
 * Logout

Subscribe for more access
JAPAN / Science & Health


EUROPEAN AGENCY SWITCHES TO RECOMMENDING NEW ALZHEIMER'S DRUG

Lecanemab was developed by drugmakers Eisai of Japan and Biogen of the United
States. | Jiji
Jiji
SHARE/SAVE
Twitter Facebook LinkedIn Email Print Bookmark story
Nov 15, 2024
Listen to this article
1 min

London –

The European Medicines Agency said Thursday that its committee evaluating
medical products has recommended partial approval of sales of lecanemab to treat
Alzheimer's disease.

The committee of the pharmaceuticals watchdog had shown a negative opinion in
July on the medicine, developed by drugmakers Eisai of Japan and Biogen of the
United States.





After conducting a reexamination as requested by the pair, however, the
committee judged that the efficacy of the medicine outweighs the risk for some
patients.

If the European Commission decides to grant sales of the medicine, it will be
the first Alzheimer's medicine available in the European Union region.

According to the EMA, the recommendation excludes patients who carry two copies
of the ApoE4 gene, considering the higher risk of side effects such as swelling
and bleeding in the brain.

Lecanemab is sold in Japan, China and the United States. Britain gave it sales
approval in August.


KEYWORDS

lecanemab(https://www.japantimes.co.jp/tag/lecanemab),
Alzheimer's(https://www.japantimes.co.jp/tag/alzheimers),
pharmaceuticals(https://www.japantimes.co.jp/tag/pharmaceuticals),
dementia(https://www.japantimes.co.jp/tag/dementia),
medicine(https://www.japantimes.co.jp/tag/medicine),
health(https://www.japantimes.co.jp/tag/health),
EU(https://www.japantimes.co.jp/tag/eu),
Eisai(https://www.japantimes.co.jp/tag/eisai),
Biogen(https://www.japantimes.co.jp/tag/biogen)
 * 
 * 
 * 

In a time of both misinformation and too much information,
quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW


MORE FROM NEWS


JAPAN TO BAN EMPLOYEES FROM WORKING FOR 14 CONSECUTIVE DAYS

Employers are currently required to provide one day off a week, but loopholes
mean some employees can work up to 48 days in a row.


SYMPOSIUM ON 1274 MONGOLIAN INVASION OF JAPAN HELD IN TOKYO




WHY THE SECURITY OF ASIA AND EUROPE ARE INSEPARABLE




JAPAN OKS INSURANCE COVERAGE OF ALZHEIMER'S DRUG DONANEMAB




CONSUMER WATCHDOG WARNS AGAINST USING FAULTY DAHON FOLDING BICYCLES




JAPAN EVOLVING, NOT ‘STAGNANT’: UC PROFESSOR SCHAEDE

It has been a long time since critics started to say Japan had entered what
became its post-bubble “lost decades.” They say its...


Sponsored
Sponsored

Body of missing German tourist found off Wakayama coast


Undo



Condition of hospitalized Japanese Princess Yuriko, 101, deteriorates


Undo



American tourist arrested over defacing of Meiji Shrine torii gate


Undo



Dating for Senior SinglesShare your feelings and emotions with
someone.Koreadates

Read More


Undo



【衝撃】恐ろしいほど当たった金運占いで人生大逆転金運上昇無料鑑定(金運占い)

今すぐ試す


Undo



預金残高100円の貧乏主婦が「7億当選」簡単に当たった方法とは…金運上昇無料鑑定【金運占い】

今すぐ試す


Undo





Ad

With your current subscription plan you can comment on stories. However, before
writing your first comment, please create a display name in the Profile section
of your subscriber account page.

Your subscription plan doesn't allow commenting. To learn more see our FAQ



 * WHAT’S TRENDING
 *  
 * Editors' Picks

U.S. intelligence head nominee made possibly hostile remarks on Japan

Japan ranked 31st in digital competitiveness, 92nd for English skills

British national arrested for over ¥13 million cash swap swindle

Princess Yuriko, sister-in-law of Emperor Showa, dies at 101

American tourist arrested over defacing of Meiji Shrine torii gate

Brutal beauty worth saving from the wrecking ball

Japan’s key political issue rests on an enduring economic myth

The sentimental gastronomies of ‘Taiwan Travelogue’

The Japanese you need to get vaccinated before winter comes

Trump's picks: A Fox News host, an ex-spy chief and the world's richest man



OUR PLANET

Tokyo's climate goals rely on a fuel that is falling out of favor
By Chris Russell



PODCAST

Kabukicho: Tokyo’s ‘stadium of desire’


LONGFORM

A boom for business tourism in Japan?
By Kathryn Wortley



SUSTAINABLE JAPAN

mission sustainability vol.12 : Kose Corp.Kose takes pride in creating beauty in
the world




SPECIAL SUPPLEMENTS

Sponsored contents planned and edited by JT Media Enterprise Division.

広告出稿に関するおといあわせはこちらまで



Read more


SUPPLEMENTS BINDER

 * Bridges by SMS
 * Global Insight
 * GMI Post
 * GATE21
 * World Eye Reports


LATEST NEWS

Top Japan diplomat makes surprise visit to Ukraine
6 hours ago
Japan issues warning over bad-faith buyers in small business M&As

Japan defense chief says no decision yet on relocating U.S. military's command

Nihon Hidankyo's crowdfunding campaign achieves initial goal on first day

Tens of thousands flee as Super Typhoon Man-yi nears Philippines



SUBSCRIBE

IN YOUR SOCIAL NETWORK

Stay up to date with us on your social media platform of choice.


IN YOUR INBOX

Get updates, insights and more via our newsletters.
SIGN ME UP
 * products & services
 * Print subscriptions
 * Group subscriptions
 * Student subscription
 * JT Digital Archives
 * Epaper Edition
 * RSS feeds

 * help & support
 * Support
 * FAQs
 * Link policy
 * Republishing
 * Contact us

 * about us
 * Company info
 * Privacy policy
 * Link policy
 * Announcements
 * Work with us
 * Advertise with us
 * Press releases

 * our sites
 * The Japan Times Alpha
 * JT Bookclub
 * The Japan Times Jobs
 * Education In Japan
 * Classifieds
 * Public notices
 * Disaster information
 * Comfacts

 * our activities
 * Sustainable Japan
 * Destination Restaurants
 * Satoyama Consortium
 * ESG Consortium

SUBSCRIBE

IN YOUR SOCIAL NETWORK

Stay up to date with us on your social media platform of choice.


IN YOUR INBOX

Get updates, insights and more via our newsletters.
SIGN ME UP
THE JAPAN TIMES LTD. ALL RIGHTS RESERVED.